Classical and biological treatments in mycosis fungoides/Sézary syndrome. New horizons in oncodermatology

Hanna R. Cisoń; Rafał K. Białynicki-Birula

doi:10.5114/ada.2024.144999

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Send email

Copy url:

abstract:

Review paper

Classical and biological treatments in mycosis fungoides/Sézary syndrome. New horizons in oncodermatology

Hanna R. Cisoń

¹

,

Rafał K. Białynicki-Birula

¹

Department and Clinic of Dermatology, Venereology and Allergology, Medical University of Wroclaw, Poland

Adv Dermatol Allergol

DOI: https://doi.org/10.5114/ada.2024.144999

Online publish date: 2024/11/14

View full text Get citation

In the strategic management of mycosis fungoides (MF)/Sézary syndrome (SS), an interdisciplinary framework is essential. The regimen typically encompasses dermatological-specific interventions, biologic response modulators, and, in advanced scenarios, systemic chemotherapeutic entities. This might integrate biologic response agents like bexarotene, histone deacetylase inhibitors such as romidepsin, and specialized monoclonal antibodies or conjugates, notably mogamulizumab and brentuximab vedotin. Decisions in therapeutic avenues are intricately individualized, considering determinants like patient age, functional health metrics, disease scope, evolutionary trajectory and previous therapeutic exposures. The high-frequency ultrasound seems to be a useful tool for monitoring infiltration of the skin. Moreover, ongoing studies are investigating novel therapeutic agents that may demonstrate efficacy in MF/SS.

keywords:

Classical and biological treatments in mycosis fungoides/Sézary syndrome. New horizons in oncodermatology

Hanna R. Cisoń 1 , Rafał K. Białynicki-Birula 1

drug therapy, diagnostic imaging, cutaneous T-cell lymphoma, mycosis fungoides, high-frequency ultrasound, immunotherapy, Sézary syndrome

Hanna R. Cisoń

¹

,

Rafał K. Białynicki-Birula

¹